SecBot SecBot
6-K ·Filed Jun 30, 2026

LKFT

Lakefront Biotherapeutics NV
NEUTRAL
Impact 2/10
Horizondays Processed3mo ago SEC0001171843-26-004401
Notable filing: 6-K
Actionable Insight • Neutral

This is a routine buyback update with no material impact on valuation or operations. Monitor next quarterly report for any guidance changes or pipeline updates.

DirectionNeutral
Confidencehigh
Horizondays
Final — all horizons settled through T+60d
LKFT ▲ +2.57% at T+60d
NEUTRAL call +2.57% · α vs SPY -0.30% · entry $29.60 → $30.36
Entry = T+0 close
Jun 30, 2026
via day close
T+1d
+2.67%
call +2.67% · α +2.80%
$30.39
settled 4mo ago
T+5d
+3.31%
call +3.31% · α +3.05%
$30.58
settled 4mo ago
T+20d
-6.35%
call -6.35% · α -4.17%
$27.72
settled 3mo ago
T+60d
+2.57%
call +2.57% · α -0.30%
$30.36
settled 5w ago

Price Chart

Loading chart...

Executive Summary

Lakefront Biotherapeutics disclosed the repurchase of 83,530 shares for €2.1M under its existing buyback program between June 22-26, 2026. The total shares held in treasury increased to 199,734. This is a routine update on the previously announced repurchase program with no material financial impact.

Key Facts

  • Repurchased 83,530 shares at an average price of €25.24 per share for a total of €2,108,045.52
  • Repurchases occurred between June 22 and June 26, 2026 under the program announced June 9, 2026
  • As of June 26, 2026, Lakefront holds 199,734 of its own ordinary shares

Financial Impact

Approximately €2.1M total repurchase (roughly 0.1% of market cap); negligible impact

share counttreasury shares

Risk Factors

  • Buyback program may not significantly reduce share count given small scale
  • No change to fundamental outlook or pipeline progress

Market Snapshot

Exchange
OTC
Sector
Pharmaceutical Preparations
Analyst Consensus
17% bullish (18 analysts)

Investment Themes

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001171843-26-004401
Document: f6k_063026.htm0001171843-26-004401
Document: 0001171843-26-004401-index-headers.html0001171843-26-004401
Document: 0001171843-26-004401-index.html0001171843-26-004401
Document: 0001171843-26-004401.txt0001171843-26-004401
11 reports for LKFT
Performance horizon
Filters
Rows
Reports for LKFT — sortable, filterable
TypeNow
Oct 20, 2026
6d ago
6-K
NEUTRAL ★ 2/10
$30.58awaiting T+20—$31.65 (+3.50%)
Oct 14, 2026
12d ago
6-K
NEUTRAL ★ 4/10
$29.93awaiting T+20—$31.65 (+5.75%)
Oct 13, 2026
13d ago
6-K
NEUTRAL ★ 2/10
$29.40awaiting T+20—$31.65 (+7.65%)
Oct 6, 2026
20d ago
6-K
NEUTRAL ★ 2/10
$30.00awaiting T+20—$31.65 (+5.50%)
Sep 1, 2026
7w ago
6-K
NEUTRAL ★ 2/10
$28.81 $29.65▲ +2.92%▲ +3.25%$31.65 (+9.86%)
Aug 25, 2026
8w ago
6-K
NEUTRAL ★ 4/10
$29.70 $30.72▲ +3.43%▲ +2.46%$31.65 (+6.57%)
Aug 12, 2026
10w ago
6-K
MIXED ★ 6/10
$27.93 $26.81▼ −4.01%▼ −2.11%$31.65 (+13.32%)
Jul 28, 2026
12w ago
6-K
NEUTRAL ★ 2/10
$27.72 $29.16▲ +5.19%▲ +0.17%$31.65 (+14.18%)
Jun 30, 2026
16w ago
6-K
NEUTRAL ★ 2/10
$29.60 $27.72▼ −6.35%▼ −4.17%$31.65 (+6.93%)
Jun 24, 2026
17w ago
6-K
NEUTRAL ★ 3/10
$29.01 $28.78▼ −0.79%▼ −2.73%$31.65 (+9.10%)
Showing 10 of 11

US Market Status

Market Closed — Opens Wed (12h 15m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 30, 2026